KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other Working Capital Changes: 2009-2025

Historic Other Working Capital Changes for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Sep 2025 value amounting to $47.9 million.

  • Regeneron Pharmaceuticals' Other Working Capital Changes rose 119.01% to $47.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $513.4 million, marking a year-over-year increase of 173.23%. This contributed to the annual value of $407.5 million for FY2024, which is 239.30% up from last year.
  • According to the latest figures from Q3 2025, Regeneron Pharmaceuticals' Other Working Capital Changes is $47.9 million, which was down 79.24% from $230.7 million recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Other Working Capital Changes registered a high of $487.3 million during Q2 2024, and its lowest value of -$252.0 million during Q3 2024.
  • For the 3-year period, Regeneron Pharmaceuticals' Other Working Capital Changes averaged around $89.6 million, with its median value being $55.3 million (2024).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first spiked by 8,328.00% in 2021, then slumped by 778.61% in 2023.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Other Working Capital Changes stood at -$76.1 million in 2021, then soared by 75.43% to -$18.7 million in 2022, then slumped by 778.61% to -$164.3 million in 2023, then soared by 133.66% to $55.3 million in 2024, then spiked by 119.01% to $47.9 million in 2025.
  • Its Other Working Capital Changes stands at $47.9 million for Q3 2025, versus $230.7 million for Q2 2025 and $179.5 million for Q1 2025.